Walcott BP, Nached BV, Mohyeldin A, Coumans J-V, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13:e69–76.

Article  PubMed  Google Scholar 

Shihabi AAI, Davarifar A, Nguyen HTL, Tavanaie N, Nelson SD, Yanagawa J, et al. Personalized chordoma organoids for drug discovery studies. Sci Adv. 2022;8:eabl3674.

Article  PubMed  PubMed Central  Google Scholar 

Denaro L, Berton A, Ciuffreda M, Loppini M, Candela V, Brandi ML, et al. Surgical management of chordoma: a systematic review. J Spinal Cord Med. 2020;43:797–812.

Article  PubMed  Google Scholar 

Bongers MER, Dea N, Ames CP, Schwawb JH. Surgical Strategies for Chordoma. Neurosurg Clin N. Am. 2020;31:251–61.

Article  PubMed  Google Scholar 

Kuang L, Lv G, Wang B, Li L, Dai Y, Li Y. Overexpression of adenosine deaminase acting on RNA 1 in chordoma tissues is associated with chordoma pathogenesis by reducing miR‑125a and miR‑10a expression. Mol Med Rep. 2015;12:93–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung YP, Diaz-Perez JA, Cote GM, Wejde J, Schwab,V Nardi JH, et al. Dedifferentiated chordoma: clinicopathologic and molecular characteristics with integrative analysis. Am J Surg Pathol. 2020;44:1213–23.

Article  PubMed  Google Scholar 

Colia V, Stacchiotti S. Medical treatment of advanced chordomas. Eur J Cancer. 2017;83:220–8.

Article  PubMed  Google Scholar 

Fletcher CBJ, Anonescu C, Merens F. WHO classification of tumours: soft tissue and bone tumours. Vol. 3 (WHO Classification of Tumours Editorial Board; 2020).

Wang L, Wu Z, Tian K, Wang K, Li D, Ma J, et al. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients. J Neurosurg. 2017;127:1257–67.

Article  PubMed  Google Scholar 

Zhang Q, Fei L, Han R, Huang R, Wang Y, Chen H, et al. Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma. Cell Discov. 2022;8:94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fischer JW, Bhattarai N. CAR-T cell therapy: mechanism, management, and mitigation of inflammatory toxicities. Front Immunol. 2021;12:693016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang M, Tang X, Zhang Z, Gu L, Wei H, Zhao S, et al. Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors. Theranostics. 2020;10:7622–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian Y, Xie D, Yang L. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. Signal Transduct Target Ther. 2022;7:117.

Article  PubMed  PubMed Central  Google Scholar 

Lanitis E, Kosti P, Ronet C, Cribioli E, Rota G, Spill A, et al. VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding. J Immunother Cancer. 2021;9:e002151.

Article  PubMed  PubMed Central  Google Scholar 

Kloss CC, Lee J, Zhang A, Chen F, Melenhorst JJ, Lacey SF, et al. Dominant-negative TGF-beta receptor enhances PSMA-targeted human CAR T cell proliferation and augments prostate cancer eradication. Mol Ther. 2018;26:1855–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 2008;26:2839–45.

Article  CAS  PubMed  Google Scholar 

Derynck R, Turley SJ, Akhurst RJ. TGFbeta biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18:9–34.

Article  PubMed  Google Scholar 

Duan W, Zhang B, Li X, Chen W, Jia S, Xin Z, et al. Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomas. Cancer Immunol Immunother. 2022;71:2185–95.

Article  CAS  PubMed  Google Scholar 

Li X, Li S, Wu B, Xu Q, Teng D, Yang T, et al. Landscape of immune cells heterogeneity in liver transplantation by single-cell RNA sequencing analysis. Front Immunol. 2022;13:890019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573–87.e3529.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin MG, et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science. 2017;355:eaai8478.

Article  PubMed  PubMed Central  Google Scholar 

Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuang C-H, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Browaeys R, Saelens W, Saeys Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17:159–62.

Article  CAS  PubMed  Google Scholar 

Zhao Y, Liu Z, Wang X, Wu H, Zhang J, Yang J, et al. Treatment with humanized selective CD19CAR-T cells shows efficacy in highly treated B-ALL patients who have relapsed after receiving murine-based CD19CAR-T therapies. Clin Cancer Res. 2019;25:5595–607.

Article  CAS  PubMed  Google Scholar 

Weber EW, Maus MV, Mackall CL. The emerging landscape of immune cell therapies. Cell. 2020;181:46–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554:544–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Xu J, Zhang B, Liu J, Liang C, Meng Q, et al. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Mol Cancer. 2019;18:184.

Article  PubMed  PubMed Central  Google Scholar 

Qiu Y, Chen T, Hu R, Zhu R, Li C, Ruan Y, et al. Next frontier in tumor immunotherapy: macrophage-mediated immune evasion. Biomark Res. 2021;9:72.

Article  PubMed  PubMed Central  Google Scholar 

Han S, Wang W, Wang S, Yang T, Zhang G, Wang D, et al. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Theranostics. 2021;11:2892–916.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas DA, Massague J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell. 2005;8:369–80.

Article  CAS  PubMed  Google Scholar 

Cao HH, Chu JH, Kwan HY, Su T, Yu H, Cheng C-Y, et al. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma. Sci Rep. 2016;6:21731.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elaimy AL, Guru S, Chang C, Ou J, Amante JJ, Zhu LJ, et al. VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP beta2-chimaerin. Sci Signal. 2018;11:eaao6897.

Article  PubMed  PubMed Central  Google Scholar 

Palazon A, Tyrakis PA, Macias D, Velica P, Rundqvist H, Fitzpatrick S, et al. An HIF-1alpha/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell. 2017;32:669–83.e665.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le X, Nilsson M, Goldman J, Reck M, Nakagawa K, Kato T, et al. Dual EGFR-VEGF pathway inhibition: a promising strategy for patients with EGFR-mutant NSCLC. J Thorac Oncol. 2021;16:205–15.

Article  CAS  PubMed  Google Scholar 

Peterson TE, Kirkpatrick ND, Huang Y, Farrar CT, Marijt KA, Kloepper J, et al. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. Proc Natl Acad Sci USA. 2016;113:4470–5.

Article  CAS  PubMed  PubMed Central